TY - JOUR
T1 - Nebulized nitric oxide/nucleophile adduct reduces pulmonary vascular resistance in mechanically ventilated septicemic sheep
AU - Bjertnaes, Lars J.
AU - McGuire, Roy
AU - Jodoin, Jeffery
AU - Salzman, Andrew L.
AU - Traber, Lillian D.
AU - Passerini, Daniel J.
AU - Smith, Daniel J.
AU - Szabo, Csaba
AU - Traber, Daniel L.
PY - 2005/3
Y1 - 2005/3
N2 - Objective: To study the effects of a novel, intermittently administered, aerosolized nitric oxide donor, methyl-N-2-dimethylaminoethyl-3-aminoproprionid/ nitric oxide (DMDE-NO), on pulmonary hemodynamic responses to sepsis. Design: Prospective, randomized, controlled study in awake sheep. Setting: Investigational intensive care unit of a university medical center. Subjects: Thirteen instrumented merino ewes weighing 36 ± 0.9 kg underwent a hemodynamic study 1 wk postoperatively. Interventions: On the day of the experiment, the sheep received a tracheotomy and mechanical ventilation was subsequently started. Pseudomonas aeruginosa bacteria were infused intravenously, beginning at time 0 hrs and continuing throughout the 48-hr experiment. The animals were randomly assigned to receive nebulized DMDE-NO 1 mg/kg, dissolved in 8 mL of saline (DMDE-NO group, n = 7), or nebulized saline alone (control group, n = 6) delivered by a nebulizer. The nebulizations started at 2, 6, 20, 24, and 43 hrs after the baseline, each time lasting for 1 hr. Measurements and Main Results: Inhaled aerosolized DMDE-NO reversibly reduced the sepsis-induced increase in pulmonary artery pressure by 13-17% and pulmonary vascular resistance index by 21-31% compared with the values registered before the administration of the drug. Systemic hemodynamics underwent an early hypodynamic phase followed by a gradual increase in cardiac index and a decrease in both mean arterial pressure and systemic vascular resistance index, but with no significant difference between groups. Gas exchange variables and plasma nitrite/nitrate did not differ significantly between groups either. Conclusions: In sheep, inhaled nebulized DMDE-NO reduces sepsis-induced changes in pulmonary hemodynamics with no change in systemic hemodynamics or gas exchange.
AB - Objective: To study the effects of a novel, intermittently administered, aerosolized nitric oxide donor, methyl-N-2-dimethylaminoethyl-3-aminoproprionid/ nitric oxide (DMDE-NO), on pulmonary hemodynamic responses to sepsis. Design: Prospective, randomized, controlled study in awake sheep. Setting: Investigational intensive care unit of a university medical center. Subjects: Thirteen instrumented merino ewes weighing 36 ± 0.9 kg underwent a hemodynamic study 1 wk postoperatively. Interventions: On the day of the experiment, the sheep received a tracheotomy and mechanical ventilation was subsequently started. Pseudomonas aeruginosa bacteria were infused intravenously, beginning at time 0 hrs and continuing throughout the 48-hr experiment. The animals were randomly assigned to receive nebulized DMDE-NO 1 mg/kg, dissolved in 8 mL of saline (DMDE-NO group, n = 7), or nebulized saline alone (control group, n = 6) delivered by a nebulizer. The nebulizations started at 2, 6, 20, 24, and 43 hrs after the baseline, each time lasting for 1 hr. Measurements and Main Results: Inhaled aerosolized DMDE-NO reversibly reduced the sepsis-induced increase in pulmonary artery pressure by 13-17% and pulmonary vascular resistance index by 21-31% compared with the values registered before the administration of the drug. Systemic hemodynamics underwent an early hypodynamic phase followed by a gradual increase in cardiac index and a decrease in both mean arterial pressure and systemic vascular resistance index, but with no significant difference between groups. Gas exchange variables and plasma nitrite/nitrate did not differ significantly between groups either. Conclusions: In sheep, inhaled nebulized DMDE-NO reduces sepsis-induced changes in pulmonary hemodynamics with no change in systemic hemodynamics or gas exchange.
KW - Hemodynamics
KW - Mechanical ventilation
KW - Nitric oxide
KW - Pulmonary hypertension
KW - Sepsis
KW - Vascular resistance
UR - http://www.scopus.com/inward/record.url?scp=14944360203&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=14944360203&partnerID=8YFLogxK
U2 - 10.1097/01.CCM.0000156282.22495.A1
DO - 10.1097/01.CCM.0000156282.22495.A1
M3 - Article
C2 - 15753755
AN - SCOPUS:14944360203
SN - 0090-3493
VL - 33
SP - 616
EP - 622
JO - Critical care medicine
JF - Critical care medicine
IS - 3
ER -